Synergistic effects of anti-oxidant agents and chemotherapeutic drugs (such as combination of gemcitabine, 5-FU, and cisplatin) resort on induction of apoptosis, inhibition of cell proliferation and metastasis invasion. [16] [17] [18] Chemo-herbal combination therapy does attenuate the hazards to inducing drug resistance and prevalence of chemotherapy side effects. 19 The present study was designed to investigate the synergistic effects of rutin and 5-FU chemo-herbal combination on apoptosis, colony formation, p53 gene expression, and Bcl-2 signaling protein in PC3 prostatic cancer cells.
Materials and Methods

Reagents
The human PC3 prostate cancer cells were provided by Pasteur Institute (Tehran, Iran). Trypsin 0.25%, fetal bovine serum (FBS), penicillin/streptomycin (pen/ strep), and RPMI 1640 medium were prepared from Gibco (Rockville, MD, USA). 5-FU (50 mg/mL solution) was purchased from Haupt Pharma (Wolfratshausen GmbH Co, Germany). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and rutin were obtained from Sigma-Aldrich (St. Louis, MO, USA). Annexin V kit was purchased from BD Bioscience (California, USA). Antibodies were purchased from Elabscience Biotechnology Co. (Wuhan, China). Roti ® ZOL total RNA extraction kit was prepared from Carl Roth GmbH (Germany). All other chemicals used were of analytical grade.
Cell viability/proliferation assay
Cell viability was measured by MTT assay test. PC3 cells were seeded in 96-well plates in RPMI 1640 medium (5000 cells/per well) supplement with 10% FBS, 1% pen/strep at 37°C in 98% humidity with 5% CO 2 for an overnight and then treated with different concentrations of 5-FU (0-10 μM) and rutin (0-1500 μM, solution in DMSO with 0.1% final concentration) for 48 hours. After treatment, medium was removed and the cells were incubated with 10 µL MTT solution (5 mg/mL) for 4 hours at 37ºC in a dark place. Then, DMSO (150 μL) was added to each well in order to dissolve the formazan crystals. Absorbance at 490 nm with a reference wavelength of 570 nm was calculated using a microplate reader (Stat Fax-2100, USA). The percentage of cell viability was assessed based on the absorbance of treated cells as opposed to the untreated control cells (viability = A (sample) / A (control) × 100).
20,21
Assessment of synergistic effects of 5-FU and rutin Synergistic effects assessment of 5-FU and rutin on PC3 cells was based on cell viability. The combined effects of both 5-FU and rutin in different concentrations (0.75 μM 5-FU and 700 μM rutin; 1 μM 5-FU and 500 μM rutin; 1.75 μM 5-FU and 300 μM rutin; and 2.5 μM 5-FU and 100 μM rutin) were assessed for 48 hours. The combination index (CI) was used to evaluate synergistic effects of 5-FU and rutin and CI ˂1, =1 and ˃1 indicated synergism, additive, and antagonism effects respectively.
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Clonogenic assay PC3 cells were cultured in 6-well plates at density of 2 × 10 2 cells/well for an overnight in RPMI 1640 medium supplement with 10% FBS, 1% pen/strep. Then, PC3 cells were treated with 5-FU (0.75 μM) or rutin (700 μM) separately and using their combination (0.75 μM and 700 μM respectively) for 48 hours. The culture medium was removed and the plates were incubated for 14 days in 5% CO 2 incubator at 37°C and 95% humidity in the absence of 5-FU and rutin treatment for detecting obvious colonies. The culture medium was changed every 2 days. Then the plates were rinsed with PBS and fixed with 70% ethanol. The staining of colonies was done with a mixture of 0.5% crystal violet in 50:50 methanol:water for 30 minutes. The plates were rinsed with water and left for drying at room temperature. Then, ImageJ software (web-based open source software) was used to evaluate the colonies. The plating efficiency (PE) was measured using the following formula: number of colonies/number of seeded cells ×100 and surviving fraction (SF) was determined by (number of colonies/number of seeded cells × PE control) ×100.
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Determining apoptosis PC3 cells (2×10 5 per well) were seeded into a 6-well plate in RPMI 1640 medium supplement with 10% FBS, 1% pen/strep and incubated overnight in 5% CO 2 incubator at 37°C and 95% humidity. Then, the cells were treated with 5-FU (0.75 μM) and rutin (700 μM) or combination of 5-FU and rutin (0.75 μM and 700 μM respectively) for 48 hours. Subsequently, the cells were collected by trypsinization and washed with PBS and stained by Annexin V/propidium (BD Biosciences) based on the manufacturer's instructions for 25 minutes at room temperature in a dark place. 25 The stained PC3 cells were analyzed using a flow cytometer (FACScan; Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). Experiments were performed in triplicates.
Real-time quantitative polymerase chain reaction PC3 cells were collected after treatment with 5-FU (0.75 μM) and rutin (700 μM) or a combination of 5-FU and rutin (0.75 μM and 700 μM, respectively) in 6-cm dishes after 48 hours. Then, total mRNA was isolated using Roti ® ZOL reagent according to the manufacturer's protocol and the RNA quantity and quality were measured by 260/280 nm absorbance ratio using NanoDrop spectrophotometer (Thermo, USA). mRNA was subsequently reversetranscribed to cDNA using synthesis kit (Takara Bio Inc., Japan). cDNA was amplified by RT-qPCR using SYBR ® Green PCR Master Mix (Takara Bio Inc, Japan) in the presence of specific primers for p53 (forward: 5'-CCCATCCTCACCATCATCACAC-3', reverse: 5'-GCACAAACACGCACCTCAAAG3'), and GAPDH (for ward: 5′ACACCCACTCCTCCACCCT T TG3′; reverse: 5′GTCCACCACCCTGTTGCTGTA-3′). The primers were designed with Oligo 6.0 (Molecular Biology Insights, Cascade, CO, USA) and confirmed by the blast (NCBI). The primers were obtained from (Macrogen Company, South Korea). The expression of p53 gene was done using Rotor-Gene 3000 (Corbett, Australia). RTqPCR program consisted of an initial denaturation stage of 95°C at 10 minutes. Then, a three-step program was developed for 40 cycles including 95°C for 10 seconds, 62°C for 15 seconds, and 72°C for 20 seconds, respectively. GAPDH (glyceraldehyde-3-phosphatedehydrogenase) a housekeeping gene, was used as an endogenous control gene for the normalization of p53 expression. The relative quantity of the target gene was determined using the 2 -ΔΔCT method.
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Western blot PC3 cells were plated into 6 dishes (6× 10 5 cells/dish) in RPMI 1640 medium supplement with 10% FBS, 1% pen/ strep and incubated overnight in 5% CO 2 incubator at 37°C and 95% humidity. The cells treated with 5-FU (0.75 μM), rutin (700 μM), and the combination of 5-FU with rutin (0.75 μM and 700 μM respectively) for 48 hours. Then, the cells were lysed on ice using RIPA buffer (50 mM Tris-HCl with pH 8, 150 mM NaCl, 1% v/v Triton 100X, 0.5% w/v sodium deoxycholate, 1 mM EDTA, 0.1% w/v sodium azide, 50 mM NaF, 0.1% sodium dodecyl sulfate, 1 mM phenylmethylsulfonyl fluoride, proteas and phosphatase inhibitor) 27 and protein concentrations were measured by Bradford reagent. 28 The protein samples were mixed with an equal volume of loading buffer (0.125 mM Tris-HCl with pH 6.8, 4% sodium dodecyl sulfate, 20% glycine, and 10% 2-mercaptoethanol) and they were boiled for 5 minutes at 98°C. Denatured proteins were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and were transferred to polyvinylidene difluoride membrane. Then membranes were placed in a blocking solution with 5% BSA for 1 hours. The membranes were washed 3 times in TBS-Tween buffer (containing 10 mM Tris with pH 7.4, 100 mM NaCl, and 0.1 mM Tween-20) for 10 minutes, and they were incubated with primary Bcl-2 and β-actin (as an internal control) antibodies according to the manufacturer's protocols at 4°C overnight. Then the membranes were washed with TBS-Tween buffer 3 times for 10 minutes and they were incubated with secondary antibody at room temperature for 2 hours. After washing the membrane 3 times for 10 minutes in TBS-Tween buffer, bands were revealed by enhanced chemiluminescence (ECL; Thermo Fisher scientific, USA).
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Statistical analysis
All data were presented as mean ± standard deviation (SD) in triplicate experiments. Statistical analysis of the data was done using SPSS software version 20 (SPSS Inc., Chicago, IL, USA) and GraphPad Prism 6 (GraphPad software, San Diego, CA). Kruskal-Wallis and Dunn's test were used to estimate the statistical analysis between the treated and the control groups for real-time PCR, Annexin V assay, clonogenic assay, and MTT assay. The p value less than 0.05 was considered significant. For gene expression analysis, the data were normalized to GAPDH and results were expressed as fold change. The relative levels of quantitative gene expression were estimated with 2 -∆∆CT method. A melting curve analysis of each product was generated to ensure the purity of the amplification product of each reaction. Combination index (CI) was calculated using CompuSyn software (Combo SynInc, City, State, USA) and CI ˂1, =1 and ˃1 were considered as synergism, additive, and antagonism effects respectively. IC 50 values of 5-FU and rutin were 3 μM and 900 μM respectively paralleling previous reports. 30 Combination of 5-FU and rutin on the PC3 cells viability showed a synergistic effect, by displaying CI reaching 0.33 (Table 1) . Cell viability by the current chemo-herbal combination was less than 30%, in agreement with previous studies. 30 It was shown that CI less than 1 and approaching zero leads to less than 50% cell viability 30 as observed by the current study.
Results and Discussion
Natural antioxidant agents and flavonoids are easily accessible through the nature, and taking advantage of their additive cytotoxic efficiency to chemotherapeutic regimens is an ongoing field of investigation to increase expression of anti-cancer genes; yet, limiting chemotherapeutic side effects. 31, 32 Antioxidant agents protect cells against superoxide and hydroxyl free radicals through reported direct and indirect pathways. 17, 33 Since 5-FU has toxic properties and clinical side effects; therefore, attempts were directed to combine 5-FU with other antioxidant agents that does reduce the therapeutic dose of 5-FU, while delaying development of drug resistance. The latter is reported to be sustained by multiple targeting mechanisms to chemo-herbal therapeutic anti-cancer combination. 18, 34 Rutin and 5-FU chemo-herbal combination investigated by the current study displayed superior impact on PC3 cell proliferation's reduction to sole application of 5-FU or rutin as observed by Wang et al. 30 The ability to reduce cancer cell proliferation using diverse chemo-herbal combination does effect through activation of apoptosis, caspases 3, 8, 9, down-regulation related to genes deemed as Bcl-2, Bcl-XL, XIAP, and potentiate mediators' expression. chemo-herbal combination used in the current study led to superior reduction in cell proliferation; though reducing 5-FU doses (Table 1 and Figure 1 ). The results were expressed as mean ± SD of three separate experiments. control cells (P < 0.05). 5-FU/rutin combination displayed superior level of Bcl-2 protein suppression in PC3 cells (Figure 4) .
Effect of 5-FU and rutin on apoptosis, gene expression of p53 and cellular pathway Bcl-2 in PC3 cell
Curcumin in association with 5-FU was reported to stimulate apoptosis, nuclear factor kappa B and p53 gene expression, and reduction to Bcl-2 protein in cancer cells, 38 paralleling the results of the current study ( Figures  2, 3, and 4) . As previously reported, 5-FU used separately or in combination with quercetin (a natural antioxidant agent), and melatonin in the setting of human liver and colon cancer cells resulted in a significant cell proliferation inhibition; thereby, empowering apoptosis.
34,39 5-FU/rutin combination investigated herein displayed similar finding in respect to cell apoptosis enhancement (Figures 1 and 2) . The latter effect on cell apoptosis, reduction in Bcl-2 gene expression and Bcl-2/Bax ratio reported 10, 40, 41 with rutin corroborates the current results (Figures 3 and 4) .
The anti-proliferative mechanism of antioxidant agents such as rutin was described occurring through prolongation of initial and final apoptosis process by over-expression of Gstp1, Cyp1A1, p38 in special. 7, 42 Anticancers chemotherapeutic properties are thought to be empowered using combination with antioxidant agents, 
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in particular by leading towards apoptosis induction. 42, 43 Increasing the Bax and caspase 3, 8, 9 expressions, designed as positive apoptosis regulator, in one hand, and reduction in Bcl-2 expression on human colon cancer cells in another, were found using combination of rutin and hyperoside. 44 Rutin alone or in combination to 5-FU/ oxaliplatin regimen in face of Caco-2 human colon cancer cells, caused phospho-Bad, cleaved caspase 3, and cleaved PARP level up-taking . 31 Antioxidant agents such as rutin cause the release of cytochrome C from mitochondria into the cytoplasm and activate apoptosis via p53. 45 The aptitude of antioxidant agents to inhibit cell proliferation and induce caspase-dependent apoptosis is sustained by activating p53 tumor suppresser protein, and downregulating MDM2. 46 5-FU has anticancer activities by increasing apoptosis through induction of p53-dependent mitochondrial pathway, releasing cytochrome C from mitochondria into cytoplasm, and activating caspase-9 and caspase3. 5-FU reduces expression of anti-apoptotic protein Bcl-2. 47 An alternative mitochondrial mechanism leading to potentiate cell apoptosis through expression of p53 (a tumor suppressor gene) that binds to Bcl-2 and Bcl-XL proteins, therefore, activating Bak and Bax apoptotic proteins is advocated. 48 Therefore, in the present study induction of PC3 cell apoptosis may be, at least partly, due to elevation of p53 gene expression plus reduction of Bcl-2 protein. In addition, our results showed that administration of rutin with 5-FU not only increases the anti-tumor effects of 5-FU but also it reduces 5-FU dose. Figure 5 displays the number of colonies in treated PC3 cell in the presence and absence of 5-FU, rutin, and their combination after 14 days. The dishes consisting of 88, 50, 33, and 9 colonies for control, 5-FU, rutin and combination of 5-FU with rutin respectively ( Figure 5B ). The number of colonies in the setting of 5-FU/rutin combination were remarkably less than that of control or separate application of 5-FU. Surviving fraction (SF) of colonies for 5-FU, rutin, and 5-FU/rutin combination were 56.8%, 37.5%, and 10.2% respectively. Figure 5A shows PE in control and treated experimental groups. PE showed a significant decrease (P < 0.05) in 5-FU/rutin combination in comparison with the control group or separately application of 5-FU. The current results pointed out that the number of colonies and Bcl-2 protein diminished in the case of 5-FU/rutin combination, compared to untreated control cells or by 5-FU application lonely ( Figures 5 and  4) . Therefore, the reduction in the number of colonies and Bcl-2 signaling protein in 5-FU/rutin combination does reflect the expected synergetic impact on PC3 cancer cells apoptosis induction.
Clonogenic assay
As the main limitation, effects of 5-FU/rutin combination on cell cycle factors such as G2, G1 and NFKappa, p38, caspases pathway, and the expression of proapoptotic genes (Bax and Bak) were not assessed by the current study. Thus, we suggest that future studies focus on the combined effects of rutin and 5-FU on the above factors.
Conclusion
The current study reported 5-FU/rutin combination as being prone to significantly inhibit PC3 cell proliferation, inducing apoptosis via down-regulation of Bcl-2, and activating the tumor suppressor protein p53 in PC3 human prostatic cancer cells. Nevertheless, further investigations are needed to assess 5-FU/rutin combination on expression of others anti or pro-apoptotic pathways.
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